Holen Sie sich die Stockscreener-App
64.10
1.55%
-1.01
Handel nachbörslich:
63.76
-0.34
-0.53%
Halozyme Therapeutics Inc Aktie (HALO) Neueste Nachrichten
Castellan Group Has $832,000 Stock Position in Halozyme Therapeutics, Inc. $HALO - MarketBeat
Strong And Rising: Halozyme Therapeutics Stock May Have More Upside - Forbes
What technical models suggest about Halozyme Therapeutics Inc.’s comebackWall Street Watch & Long-Term Capital Growth Ideas - newser.com
Using data tools to time your Halozyme Therapeutics Inc. exitQuarterly Portfolio Report & Smart Money Movement Alerts - newser.com
Heatmap analysis for Halozyme Therapeutics Inc. and competitors2025 Support & Resistance & Fast Gain Swing Alerts - newser.com
Tectonic Advisors LLC Decreases Holdings in Halozyme Therapeutics, Inc. $HALO - MarketBeat
Halozyme Therapeutics (NASDAQ:HALO) Upgraded by Weiss Ratings to "Buy (B-)" Rating - MarketBeat
Key metrics from Halozyme Therapeutics Inc.’s quarterly data2025 Top Decliners & Short-Term Swing Trade Alerts - newser.com
Halozyme Therapeutics Inc Stock Analysis and ForecastProtective Put Strategies & Budget Friendly Portfolio - earlytimes.in
Can Elektrofi Acquisition Drive Halozyme's Long-Term Growth? - Yahoo Finance
Halozyme Therapeutics (NASDAQ:HALO) Downgraded by Zacks Research to Hold - MarketBeat
Zacks Research Analysts Increase Earnings Estimates for HALO - MarketBeat
Halozyme Therapeutics (HALO): What Recent Gains Reveal About Its Current Valuation - Yahoo
Halozyme Therapeutics Experiences Evaluation Revision Amidst Mixed Market Signals - Markets Mojo
Halozyme Appoints New Chief Operating Officer - The Globe and Mail
Halozyme Therapeutics Names Cortney Caudill Chief Operating Officer - MarketScreener
Halozyme (HALO) Appoints New Chief Operating Officer - GuruFocus
Halozyme names Cortney Caudill as COO - TipRanks
Halozyme Therapeutics appoints Cortney Caudill as chief operating officer - Investing.com
Halozyme Therapeutics, Inc. Announces Appointment of Cortney Caudill as Senior Vice President and Chief Operating Officer, Effective October 1, 2025 - MarketScreener
Are Medical Stocks Lagging Armata Pharmaceuticals (ARMP) This Year? - Nasdaq
Pattern recognition hints at Halozyme Therapeutics Inc. upsideEarnings Overview Summary & Risk Managed Trade Strategies - newser.com
FY2025 EPS Forecast for Halozyme Therapeutics Cut by Analyst - MarketBeat
How buybacks impact Halozyme Therapeutics Inc. stock valueWeekly Trade Summary & Technical Pattern Based Signals - newser.com
How geopolitical risks impact Halozyme Therapeutics Inc. (RV7) stock2025 Support & Resistance & Capital Protection Trading Alerts - newser.com
Will Halozyme Therapeutics Inc. (RV7) stock outperform global peersWeekly Stock Analysis & AI Based Trade Execution Alerts - newser.com
33,600 Shares in Halozyme Therapeutics, Inc. $HALO Acquired by LGT Fund Management Co Ltd. - MarketBeat
111 Capital Makes New Investment in Halozyme Therapeutics, Inc. $HALO - MarketBeat
Halozyme Therapeutics (NASDAQ:HALO) CEO Sells $1,380,600.00 in Stock - MarketBeat
Insider Selling: Halozyme Therapeutics (NASDAQ:HALO) CEO Sells 20,000 Shares of Stock - MarketBeat
Halozyme Announces Merger Agreement with Elektrofi - TipRanks
Halozyme Therapeutics says if deal is terminated under certain circumstances, co to pay Elektrofi reverse termination fee of $36 million - MarketScreener
Benchmark Sees More Upside for Halozyme Therapeutics (HALO), Hikes Price Target - MSN
Research Analysts Set Expectations for HALO FY2026 Earnings - MarketBeat
Institutional scanner results for Halozyme Therapeutics Inc.2025 Top Gainers & Daily Price Action Insights - newser.com
Is it too late to sell Halozyme Therapeutics Inc.Market Growth Summary & Free High Return Stock Watch Alerts - newser.com
Public Employees Retirement System of Ohio Acquires 38,049 Shares of Halozyme Therapeutics, Inc. $HALO - MarketBeat
Can volume confirm reversal in Halozyme Therapeutics Inc.July 2025 Gainers & Low Drawdown Investment Strategies - newser.com
Halozyme Therapeutics (NASDAQ:HALO) Shares Down 4.3% on Insider Selling - Defense World
What analysts say about Halozyme Therapeutics Inc RV7 stockStock Price Divergence & Small Investment Portfolio - earlytimes.in
Halozyme Acquires Elektrofi to Enhance Drug Delivery - MSN
Halozyme to acquire Elektrofi, a biopharma focused on drug delivery - MSN
Halozyme Therapeutics (NASDAQ:HALO) Trading Down 4.3% on Insider Selling - MarketBeat
HC Wainwright Increases Halozyme Therapeutics (NASDAQ:HALO) Price Target to $90.00 - MarketBeat
HC Wainwright & Co. Maintains Halozyme Therapeutics (HALO) Buy Recommendation - Nasdaq
Halozyme stock price target raised to $90 from $85 at H.C. Wainwright - Investing.com
Halozyme eyes microparticles in $900m Elektrofi acquisition - Yahoo Finance
AMI Asset Management Corp Sells 16,475 Shares of Halozyme Therapeutics, Inc. $HALO - MarketBeat
HC Wainwright & Co. Raises Price Target for Halozyme Therapeutics (HALO) | HALO Stock News - GuruFocus
H.C. Wainwright Maintains Halozyme Therapeutics(HALO.US) With Buy Rating, Raises Target Price to $90 - 富途牛牛
Bernadette Connaughton Sells 2,000 Shares of Halozyme Therapeutics (NASDAQ:HALO) Stock - MarketBeat
Insider Sell: Bernadette Connaughton Sells 2,000 Shares of Haloz - GuruFocus
Connaughton of Halozyme sells $150k in stock By Investing.com - Investing.com Australia
Connaughton of Halozyme sells $150k in stock - Investing.com India
5.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):